China NT Pharma Group Company Ltd. manufactures generic pharmaceuticals, and offers logistics and promotions and sales service to other drug manufacturers. The Company offers customs clearance, warehousing, delivery, invoicing, receivables collection and other services; and promotion and sales services primarily for anti-infective and central nervous system medications.

Exchange Notice - Resumption Of Trading

Announcements and Notices - [Final Results / Inside Information / Termination of Transaction / Very Substantial Acquisition / Other - Business Update]

Supplemental Announcement To Termination Of The Very Substantial Acquisition And The Annual Report For The Year Ended 31 December 2023

Announcements and Notices - [Inside Information / Announcement by Offeree Company under the Takeovers Code / Unusual Price/Turnover Movements - Qualified / Resumption]

(1) Announcement Pursuant To Rule 3.7 Of The Takeovers Code, Rule 13.09 (2) Of The Listing Rules And Inside Information Provisions; And (2) Resumption Of Trading

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

China Nt Pharma Group (1011 HK)

Exchange Notice - Resumption Of Trading

Supplemental Announcement To Termination Of The Very Substantial Acquisition And The Annual Report For The Year Ended 31 December 2023

(1) Announcement Pursuant To Rule 3.7 Of The Takeovers Code, Rule 13.09 (2) Of The Listing Rules And Inside Information Provisions; And (2) Resumption Of Trading

Trading Halt

Exchange Notice - Trading Halt

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)